80 related articles for article (PubMed ID: 7006273)
1. Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence.
Ek A; Andersson KE; Gullberg B; Ulmsten U
Zentralbl Gynakol; 1980; 102(15):839-44. PubMed ID: 7006273
[TBL] [Abstract][Full Text] [Related]
2. The effects of long-term treatment with norephedrine on stress incontinence and urethral closure pressure profile.
Ek A; Andersson KE; Gullberg B; Ulmsten U
Scand J Urol Nephrol; 1978; 12(2):105-10. PubMed ID: 358381
[TBL] [Abstract][Full Text] [Related]
3. The effect of phenylpropanolamine on female stress urinary incontinence.
Lehtonen T; Rannikko S; Lindell O; Talja M; Wuokko E; Lindskog M
Ann Chir Gynaecol; 1986; 75(4):236-41. PubMed ID: 3535621
[TBL] [Abstract][Full Text] [Related]
4. Measurement of urethral closure function in women with stress urinary incontinence.
Klarskov N; Scholfield D; Soma K; Darekar A; Mills I; Lose G
J Urol; 2009 Jun; 181(6):2628-33; discussion 2633. PubMed ID: 19375093
[TBL] [Abstract][Full Text] [Related]
5. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
[TBL] [Abstract][Full Text] [Related]
6. The effects of norephedrine and bethanechol on the human urethral closure pressure profile.
Ek A; Andersson KE; Ulmsten U
Scand J Urol Nephrol; 1978; 12(2):97-104. PubMed ID: 358385
[TBL] [Abstract][Full Text] [Related]
7. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients.
Collste L; Lindskog M
Urology; 1987 Oct; 30(4):398-403. PubMed ID: 3310369
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.
Ahlström K; Sandahl B; Sjöberg B; Ulmsten U; Stormby N; Lindskog M
Gynecol Obstet Invest; 1990; 30(1):37-43. PubMed ID: 2227611
[TBL] [Abstract][Full Text] [Related]
9. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Wein AJ
J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
[No Abstract] [Full Text] [Related]
10. A double-blind trial of fentonium bromide in the treatment of incontinent unstable bladder.
Milani R; Merlo E; Scalambrino S; Viganò R
Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):421-4. PubMed ID: 3531034
[TBL] [Abstract][Full Text] [Related]
11. Adrenergic innervation and adrenergic mechanisms. A study of the human urethra.
Ek A
Acta Pharmacol Toxicol (Copenh); 1978; 43 Suppl 2():35-40. PubMed ID: 568874
[TBL] [Abstract][Full Text] [Related]
12. Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women.
Kinn AC; Lindskog M
Urology; 1988 Sep; 32(3):273-80. PubMed ID: 3046105
[TBL] [Abstract][Full Text] [Related]
13. The effect of alpha-adrenergic stimulation in stress incontinence.
Obrink A; Bunne G
Scand J Urol Nephrol; 1978; 12(3):205-8. PubMed ID: 214851
[TBL] [Abstract][Full Text] [Related]
14. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
Nijman RJ; Borgstein NG; Ellsworth P; Djurhuus JC
J Urol; 2005 Apr; 173(4):1334-9. PubMed ID: 15758796
[TBL] [Abstract][Full Text] [Related]
15. Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence?
Blonski J
J Fam Pract; 2001 Dec; 50(12):1017. PubMed ID: 11742595
[No Abstract] [Full Text] [Related]
16. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.
Davila GW; Daugherty CA; Sanders SW;
J Urol; 2001 Jul; 166(1):140-5. PubMed ID: 11435842
[TBL] [Abstract][Full Text] [Related]
17. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
[TBL] [Abstract][Full Text] [Related]
18. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial.
Jackson S; Shepherd A; Brookes S; Abrams P
Br J Obstet Gynaecol; 1999 Jul; 106(7):711-8. PubMed ID: 10428529
[TBL] [Abstract][Full Text] [Related]
19. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
Robinson D; Cardozo L; Terpstra G; Bolodeoku J;
BJU Int; 2007 Oct; 100(4):840-5. PubMed ID: 17822465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
